4//SEC Filing
MACKENZIE ALEXANDER R 4
Accession 0001225208-21-004321
CIK 0000078003other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:59 PM ET
Size
11.4 KB
Accession
0001225208-21-004321
Insider Transaction Report
Form 4
PFIZER INCPFE
MACKENZIE ALEXANDER R
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2021-02-27$22.35/sh+29,838$666,879→ 153,338 total - Tax Payment
Common Stock
2021-02-27$34.64/sh−18,919$655,354→ 128,607 total - Exercise/Conversion
Stock Appreciation Rights
2021-02-27−29,838→ 0 totalExercise: $22.35From: 2021-02-27Exp: 2021-02-27→ Common Stock (29,838 underlying) - Tax Payment
Common Stock
2021-02-27$33.49/sh−5,812$194,644→ 147,526 total
Holdings
- 10,111(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (5)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]Price is the closing price of Pfizer common stock on February 26, 2021.
- [F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Documents
Issuer
PFIZER INC
CIK 0000078003
Entity typeother
Related Parties
1- filerCIK 0001678459
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:59 PM ET
- Size
- 11.4 KB